Purdue Case Could Transform Patent Obviousness Analyses
A pending petition for certiorari to the U.S. Supreme Court by Purdue Pharma could significantly shift how courts weigh secondary considerations in patent obviousness analyses. In this analysis, we explore the...To view the full article, register now.
Already a subscriber? Click here to view full article